p53 codon 72 polymorphism in cervical cancers and its correlation with HPV16, 18E6

Journal of Sichuan University (Medical Science)

Volumn 37, Issue 3, 2006, Pages 404-407

  Hou, Min Min ^a   Xi, Ming Rong ^a   Cao, Ze Yi ^a   Yang, Kai Xuan ^a   Sun, Zhi Lin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasm; HRHPV,E6; p53 codon 72 polymorphism

Indexed keywords

PROTEIN P53;

ARTICLE; CODON; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

EID: 33744795990     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Thomas M, Massimi P, Jenlins J, et al. HPV-18 E6mediated inhibition of p53 binding activity is independent of E6 induced degradation. Oncogene, 1995; (10): 261-268.
2. Matlashewski GJ, Tuck S, Pim D, et al. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 1987;(7):961-963.
3. Storey A, Thomas M, Kalita S, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 1998;393(21):229-234.
4. Filippva M, Song H, Connolly JL, et al. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cell from TNF-induced apoptosis. Biol Chem, 2002;277(24):21730-21739.
5. Xi MR, He YD, Yang XY, et al. The preliminary study on the relationship between HPV-associated cervical cancer and p53 codon 72 polymorphism in Sichuan Province. The Chinese-German Journal of Clinical Oncology, 2003;2(3):160-162.
6. Kang SB, Lee HP. p53 codon 72 polymorphism and cervical adenocarcinoma risk in Korean women. Cancer Res and Treat, 2001;33(3):243-249.
7. Pegoraro RJ, Rom L, Lanning PA, et al. p53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer, 2002;12(4):383-388.
8. Purdie K. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human pappilomavirus. Cancer Res, 1993;53(9):5328-5333.
9. McGregor JM, Harwood CA, Brooks L, et al. Relationship between p53 codon 72 polymorphism and susceptibility to sunborn and skin cancer. J Invest Dermatol, 2002;119(1):84-90.
10. Soulitzis N, Sourvinos G, Dokianakis DN, et al. P53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett, 2002;179(2):175-183.
11. Andersson S, Rylander E, Strand A, et al. The significance of p53 codon 72 polymorphism for development of cervical adenocarcinoma. Br J Cancer, 2001;85(8):153-156.